Trademark Overview
On Monday, February 17, 2025, a trademark application was filed for ROCKFISH BIO with the United States Patent and Trademark Office. The USPTO has given the ROCKFISH BIO trademark a serial number of 79421383. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Wednesday, July 23, 2025. This trademark is owned by Rockfish Bio AG. The ROCKFISH BIO trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Reagents and assays for medical or veterinary use; pharmaceuticals; pharmaceuticals for the treatment and prevention of chronic diseases; pharmaceuticals for the treatment and prevention of age-related disorders and diseases and neurodegenerative disorders and diseases; pharmaceuticals for healthy ageing; pharmaceuticals for the treatment and prevention of disorders and diseases linked to senescent cell accumulation.
Assays and reagents for scientific and research use; diagnostic reagents for scientific use; senolytics
Human healthcare services; medical and healthcare services; medical testing for diagnostic or treatment purposes; medical analysis services relating to the treatment of patients; medical testing services relating to the diagnoses and treatment of diseases; consultancy and information services relating to medical, pharmaceutical and biopharmaceutical products; provision of medical treatment for prophylaxis or therapy; medical and healthcare services in the field of personalized medicine; services of personalized medical treatment for prevention of chronic diseases, age-related disorders and diseases and neurodegenerative disorders and diseases; information consultancy and advisory services in relation to the aforesaid.
Scientific research and development; scientific research and development in the fields of senolytics, age-related disorders and diseases and neurodegenerative disorders and diseases therapies; services related to scientific research, development and production of pharmaceutical and biopharmaceutical agents and preparations; services in the field of research, development and production of medical, pharmaceutical and biopharmaceutical products; medical- and pharmacological research services; pharmaceutical, biopharmaceutical drug development services; drug discovery services; providing medical and scientific research information in the field of clinical trials.
